A ruling by the Beijing Intellectual Property Court on 15 April came amid hopes that a newly established patent linkage system in China will make it easier for drug patent holders to file infringement lawsuits against generics makers in the country.
Revisions to Chinese Patent Law last 4 July and the subsequent provision of patent linkage required a dedicated drug patent...